HIGHLIGHTS
- who: Marc G. Vervloet from the , HV, The Netherlands have published the research work: Shedding Light on the Complex Regulation of FGF23, in the Journal: Metabolites 2022, 12, 401. of /2022/
- future: While some of these physiological or pathological factors like inflammatory cytokines may partially confound the association of and clinical endpoints others are in the same causal path are targetable and hence hold the promise of future treatment options to alleviate FGF23-driven toxicity for instance in chronic kidney disease the FGF23-associated disease with the highest prevalence by far.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.